Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories consecutive Years of Dividend Increases (Years — S&P 500 Dividend Aristocrat)
Form 8-K Earnings Releases ('increased its dividend payout for 54 consecutive years')
Latest, FY2026
54
Period ended Dec 31, 2026
Change on a year earlier
0.0%
54 in FY2025
History
10 years
Since FY2016
Sources
10
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consecutive Years of Dividend Increases (Years — S&P 500 Dividend Aristocrat) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Dec 31, 2026 | 54 | 0.0% | SEC Filing (0001628280-26-066601) ↗ |
| FY2025 | Dec 31, 2025 | 54 | +1.9% | SEC Filing (0001628280-26-002982) ↗ |
| FY2024 | Dec 31, 2024 | 53 | +1.9% | SEC Filing (0001628280-25-002092) ↗ |
| FY2023 | Dec 31, 2023 | 52 | +2.0% | SEC Filing (0001628280-24-002009) ↗ |
| FY2022 | Dec 31, 2022 | 51 | +2.0% | SEC Filing (0001628280-23-001516) ↗ |
| FY2021 | Dec 31, 2021 | 50 | – | SEC Filing (0001104659-22-007648) ↗ |
| FY2019 | Dec 31, 2019 | 47 | 0.0% | SEC Filing (0001104659-19-040664) ↗ |
| FY2018 | Dec 31, 2018 | 47 | +2.2% | SEC Filing (0001104659-19-002848) ↗ |
| FY2017 | Dec 31, 2017 | 46 | +2.2% | SEC Filing (0001104659-18-003691) ↗ |
| FY2016 | Dec 31, 2016 | 45 | – | SEC Filing (0001104659-17-003920) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Consecutive Years of Dividend Increases (Years — S&P 500 Dividend Aristocrat), annual FY2016–FY2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/div-consec-yrs
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.